AI Overview
What is IPO GMP? IPO GMP (Grey Market Premium) is the unofficial per-share premium at which an upcoming IPO’s shares trade in India’s informal grey market before the company officially lists on NSE or BSE. It is expressed in rupees. If an IPO is priced at ₹200 and the GMP is ₹80, the implied listing price is ₹280 a 40% grey market premium. GMP is tracked daily as a sentiment indicator, but it is unregulated, unverified, and not always an accurate predictor of the actual listing price.
Key terms at a glance:
| Term | Meaning |
| GMP | Grey Market Premium per-share unofficial premium |
| Kostak Rate | Fixed amount paid for an entire IPO application, regardless of allotment |
| Subject to Sauda (STS) | Conditional deal settles only if the seller gets allotment |
| Estimated Listing Price | Issue price + GMP |
| Negative GMP | Market expects listing below issue price |
Introduction: The Number Every IPO Investor Checks First
You have applied for an IPO. Or you are about to. Either way, there is one number you are probably already searching for: the GMP.
Every active IPO investor in India knows the feeling. The subscription window is open, the allotment date is still days away, and you want some indication any indication of how the stock might open on listing day. That is where the grey market premium enters the conversation.
IPO GMP is one of the most searched financial terms in India during every IPO season. Retail investors, HNIs, and even experienced traders check GMP figures daily, sometimes multiple times a day. Yet despite its popularity, GMP is widely misunderstood. Many investors treat it as a reliable prediction. It is not. It is a signal and understanding the difference between a signal and a guarantee can protect you from costly mistakes.
This guide explains exactly what IPO GMP means, how it is calculated, where it comes from, what Kostak and Subject to Sauda rates mean, and most importantly how reliably GMP actually predicts the listing price in practice.
What is IPO GMP? The Clear Definition
IPO GMP stands for Grey Market Premium. It is the unofficial amount, in rupees per share, at which IPO shares are bought and sold in the grey market before the stock officially lists on the National Stock Exchange (NSE) or Bombay Stock Exchange (BSE).
The grey market itself is an informal, over-the-counter marketplace. It has no electronic order book, no central clearinghouse, and no oversight from SEBI, NSE, or BSE. Transactions happen through personal networks, phone calls, and messaging groups primarily concentrated in trading communities in cities like Mumbai, Ahmedabad, Surat, and Rajkot.
When investors and grey market dealers collectively believe an IPO will list at a higher price than its issue price, they are willing to pay a premium for those shares right now before allotment, before listing, before the official market opens. That premium is the GMP.
A simple example:
Suppose an IPO has an upper price band of ₹150 per share. Ahead of listing, grey market dealers are trading these shares at ₹210. The GMP is ₹60 (₹210 minus ₹150). This means grey market participants collectively expect the stock to list somewhere around ₹210 giving allotted investors a potential gain of ₹60 per share on listing day.
If the GMP falls below zero, say, the grey market price is ₹130 against an issue price of ₹150 that is called a negative GMP or grey market discount. It signals that the market expects the stock to list below its issue price.
How the Grey Market Actually Works
Understanding GMP requires understanding the grey market itself, because the two are inseparable.
The grey market is not a building, a platform, or an app. It is a trust-based informal network that has operated in India for decades. Before SEBI-regulated primary markets became as accessible as they are today, grey market activity was even more widespread. Today it continues to function as a pre-listing price discovery mechanism.
Here is how transactions work in practice:
Share-based transactions involve a grey market buyer purchasing the right to receive your allotted shares after listing. If you receive allotment, you transfer the shares to the buyer at the agreed price. If you do not receive allotment, the deal typically collapses. The buyer bears the allotment risk in exchange for the expected listing upside.
Application-based transactions involve selling your entire IPO application to a grey market buyer before allotment results are announced. This is where Kostak and Subject to Sauda rates come in explained in detail below.
All of this operates entirely on mutual trust. There is no written contract enforceable by law. Settlement happens informally after listing, typically through cash or bank transfers. Counterparty risk is real and entirely unmitigated.
How is IPO GMP Calculated?
GMP itself is not calculated using a formula it emerges organically from buying and selling activity in the grey market, just as a stock price emerges from supply and demand on an exchange.
However, there are two derived calculations that investors use regularly:
Estimated Listing Price
This is the most widely used application of GMP data:
Estimated Listing Price = Issue Price (Upper Price Band) + GMP
Example: If an IPO has a price band of ₹100 to ₹120, and the GMP is ₹45, the estimated listing price is ₹120 + ₹45 = ₹165.
GMP Percentage (Expected Listing Gain %)
GMP % = (GMP / Issue Price) × 100
Example: GMP of ₹45 on an issue price of ₹120 = (45 / 120) × 100 = 37.5% expected listing gain
This percentage figure is what you see quoted on most GMP tracking websites, including our live IPO GMP Today tracker.
Context matters enormously when reading GMP percentages. A ₹30 GMP on a ₹100 issue price signals a 30% premium very strong sentiment. The same ₹30 GMP on a ₹500 issue price signals only a 6% premium a very different picture.
What Factors Influence IPO GMP?
GMP is not random. Several factors push it higher or lower in the days between subscription opening and listing:
- IPO subscription numbers are the single biggest driver. When retail subscription crosses 10x, 20x, or more, GMP tends to rise sharply. Heavily oversubscribed IPOs, especially at the QIB category level, signal strong institutional confidence and the grey market prices that in quickly.
- Anchor investor quality plays a significant role. When prestigious domestic mutual funds and foreign institutional investors participate in an IPO’s anchor allocation, grey market participants interpret it as a quality stamp. GMP typically rises after strong anchor investor announcements.
- Broader market conditions matter just as much as IPO-specific factors. A strong Nifty rally in the days before listing tends to lift GMP across multiple IPOs simultaneously. A sharp market correction can drag GMP down even for fundamentally strong companies.
- Company fundamentals and valuation shape the baseline expectation. IPOs with strong revenue growth, healthy profit margins, and reasonable P/E valuations relative to peers tend to start with higher GMP. Overvalued IPOs or companies with losses often attract negative or near-zero GMP even before subscription opens.
- Promoter reputation and group track record create what some analysts call a “halo premium.” Companies from promoter groups with a history of strong listing gains enjoy elevated GMP even before detailed analysis catches up.
- SME vs Mainboard distinction is important. SME IPO GMP tends to be more volatile, with steeper rises and sharper collapses. Mainboard IPO GMP is generally more stable but also tends to reflect institutional interest more accurately.
What is Kostak Rate in IPO?
Kostak is a specific grey market concept that confuses many first-time IPO investors. Here is a clear explanation.
Kostak rate is the fixed price a grey market buyer pays for an entire IPO application, regardless of whether the seller receives allotment.
It is a risk-transfer mechanism. The seller wants a small, guaranteed return. The buyer is willing to take on the allotment risk and the listing risk in exchange for the potential upside.
Example:
- An IPO has an upper price band of ₹200 and a lot size of 75 shares (minimum investment ₹15,000)
- The Kostak rate is ₹800 per application
- You apply for one lot and sell your application in the grey market at the Kostak rate
- You receive ₹800 regardless of what happens next
- If you receive allotment and the stock lists at ₹250, the buyer receives the allotted shares and profits ₹50 × 75 = ₹3,750 minus the ₹800 Kostak paid to you
- If you do not receive allotment, the buyer loses ₹800
From the seller’s perspective, Kostak converts an uncertain listing gain into a guaranteed fixed return. From the buyer’s perspective, it is a leveraged bet on both allotment and listing performance.
Kostak rates are typically quoted for applications at both the ₹2 lakh (retail category) and ₹10 lakh (HNI category) application sizes, since allotment probability and lot-level gains differ between categories.
What is Subject to Sauda (STS) in IPO Grey Market?
Subject to Sauda often abbreviated as STS or “Sub2” is a conditional grey market deal that settles only if the seller actually receives allotment.
Example:
- The STS rate for an IPO is quoted at ₹3,500 per lot
- You apply for one lot and enter an STS agreement with a grey market buyer
- If you receive allotment: you transfer the shares, and the buyer pays you ₹3,500 above the issue price (effectively locking in your gain at ₹3,500 per lot regardless of where the stock actually lists)
- If you do not receive allotment: no deal, no payment, no obligation
STS differs from Kostak in one critical way: it is contingent on allotment. This makes STS rates closely correlated with GMP and expected listing price. Kostak, by contrast, includes an allotment risk premium which is why Kostak rates are always lower than the equivalent STS payout.
For heavily oversubscribed IPOs where allotment is uncertain, STS rates can be significantly higher than Kostak rates because the buyer knows allotment probability is low.
Quick Comparison: GMP vs Kostak vs Subject to Sauda
| Feature | GMP | Kostak | Subject to Sauda (STS) |
| What it measures | Per-share expected premium | Fixed price per application | Conditional price per allotted lot |
| Allotment required? | Implied (share deal) | No | Yes |
| Risk to seller | None (if share deal) | None | None (no allotment = no deal) |
| Risk to buyer | Listing performance | Allotment + listing | Listing performance only |
| Expressed as | ₹ per share | ₹ per application | ₹ per lot |
| Legality | Unregulated | Unregulated | Unregulated |
Is IPO GMP Reliable? The Honest Answer
This is the question that matters most and the honest answer is: directionally useful, not precisely predictable.
Historical data on Indian IPOs from 2020 to 2025 suggests that GMP’s directional accuracy (whether the stock lists at a gain or a loss) is roughly 70 to 75 percent. That sounds respectable, until you consider the other 25 to 30 percent of cases where high GMP preceded flat or negative listings, or where low GMP preceded a strong debut.
Where GMP Has Failed Investors
Several well-documented patterns show GMP’s limitations:
High GMP, disappointing listing: Some IPOs with GMP in the range of 40% to 60% have listed flat or at a discount when broader market conditions deteriorated in the days before listing. Market-level risk is not priced into GMP at all it captures IPO-specific sentiment but not macro shocks.
Low or negative GMP, strong listing: Certain IPOs with muted grey market activity have listed at strong premiums when institutional demand on listing day exceeded expectations. GMP reflects grey market participants’ sentiment, which is not the same as the full market’s sentiment.
SME IPO GMP manipulation: The relatively small scale of SME IPOs makes grey market pricing easier to move with limited capital. There have been documented cases where GMP was artificially inflated ahead of listing, only for the stock to list at a significant discount.
Structural Reasons GMP Can Be Wrong
Volume is tiny. Grey market transactions represent a minuscule fraction of the total shares offered in even a mid-sized IPO. A few hundred informal trades among a relatively small network of dealers cannot accurately represent demand from lakhs of applicants nationwide.
Data is unverified. No regulatory body records or audits grey market transactions. The GMP figures you see on websites including this one come from market intelligence and dealer networks. They are estimates, not official prices.
Manipulation is possible. Promoters, operators, or large applicants could theoretically push GMP up or down to influence retail sentiment. There is no mechanism to prevent this.
GMP changes rapidly. A GMP that was ₹80 on Monday can be ₹40 by Thursday if subscription numbers disappoint or the broader market falls. Treating a GMP reading from days before listing as an accurate prediction of the listing price ignores how much it can shift in the interim.
What to Use Alongside GMP
If you are tracking GMP to inform an IPO investment decision, these official data points deserve equal or greater weight:
- Subscription data: Retail, NII, and QIB subscription multiples available in real time on BSE and NSE during the subscription window
- QIB subscription level: High QIB oversubscription is consistently one of the stronger signals of listing performance
- Anchor investor list: The quality and reputation of anchor investors, published before the IPO opens
- Company financials: Revenue growth, profitability, debt levels, and P/E ratio relative to listed peers
- Use of proceeds: Whether funds raised go to business growth (fresh issue) or promoter exits (OFS)
You can cross-check live subscription data on our IPO Subscription Status pages, and read our analysis on each IPO’s allotment and listing expectations.
Where to Check IPO GMP in India
There is no official source for GMP data by definition, since it is an unregulated market. The figures you see across websites come from grey market dealer networks and are reported as market intelligence.
Reliable sources for cross-checking GMP include:
- iposhareprice.com/gmp/ipo-gmp-today/ our live GMP tracker, updated daily from cross-verified sources
- IPOWatch and InvestorGain among the most widely followed GMP aggregators
- IPOCentral useful for discussions and community-sourced GMP data
One important practice: always cross-check GMP across at least two or three sources. If sources diverge significantly, treat the data with additional skepticism. Large discrepancies between GMP readings on different platforms often indicate data lag, dealer disagreements, or thin market activity.
GMP for Mainboard vs SME IPOs: Key Differences
GMP behaves differently across IPO categories, and understanding this distinction matters for how you interpret the numbers.
- Mainboard IPO GMP tends to be more stable and more reflective of genuine institutional demand. Mainboard IPOs involve larger companies with SEBI’s full listing requirements, typically attracting wider analyst coverage, more institutional participation, and a broader retail base. When a Mainboard IPO shows strong GMP supported by high QIB subscription, the signal is meaningfully more reliable.
- SME IPO GMP tends to be more volatile and more susceptible to manipulation. SME IPOs list on NSE SME or BSE SME platforms and involve smaller companies with lower public float. The grey market for SME IPOs is thinner fewer participants, smaller transaction sizes which makes it easier for prices to move on limited volume. In 2024 and 2025, several SME IPOs with very high GMP listed at or below issue price, prompting SEBI to increase scrutiny of the SME IPO ecosystem.
For SME IPOs especially, treat GMP as a rough sentiment indicator and place much greater weight on fundamentals, subscription data, and promoter quality.
Common Misconceptions About IPO GMP
- Misconception 1: High GMP means guaranteed listing gain. Reality: GMP is a sentiment signal. Market conditions on listing day, actual demand from institutional and retail buyers, and macro factors can all cause the actual listing price to diverge significantly from what GMP implied.
- Misconception 2: GMP is official data. Reality: GMP comes from an unregulated, informal market with no SEBI oversight. It is not audited, verified, or endorsed by any regulatory body. Treat it as intelligence, not data.
- Misconception 3: GMP only matters on listing day. Reality: GMP trend matters as much as the absolute level. A GMP that started at ₹100 and has fallen to ₹40 in three days signals deteriorating sentiment potentially more important than the current ₹40 number.
- Misconception 4: Negative GMP always means a loss. Reality: While negative GMP is a clear warning sign, some IPOs with negative GMP have listed flat or even at a small gain when broader market conditions improved dramatically in the final days before listing.
- Misconception 5: Participating in grey market transactions is a standard investing activity. Reality: Grey market activity is entirely outside SEBI’s regulatory framework. There is no legal recourse if a counterparty defaults. It is not the same as applying for an IPO through a regulated broker.
Frequently Asked Questions (FAQ)
What does IPO GMP mean in simple terms?
IPO GMP (Grey Market Premium) is the unofficial extra amount investors are willing to pay for an IPO’s shares before the company lists on the stock exchange. It indicates market sentiment about the expected listing price.
How is IPO GMP calculated?
GMP is not calculated using a formula it emerges from informal buying and selling activity. The estimated listing price is calculated as: Issue Price + GMP. The GMP percentage is: (GMP / Issue Price) × 100.
Is IPO GMP legal in India?
The grey market itself is unregulated and outside SEBI’s framework. Tracking and monitoring GMP as a data point is legal. Participating in grey market transactions (buying or selling IPO applications or shares before listing) operates in a legal grey area with no regulatory protection.
What is a good GMP for an IPO?
There is no universal benchmark. Generally, a GMP percentage above 20% indicates positive market sentiment. However, GMP direction and trend matter more than any single reading. A rising GMP supported by strong subscription and QIB data is more meaningful than a high but declining GMP.
What does negative GMP mean?
Negative GMP means grey market participants expect the stock to list below its issue price. It is a warning signal but not a guarantee of a loss. Always verify with subscription data and fundamentals before making a final decision.
What is the difference between Kostak and Subject to Sauda?
Kostak is a fixed payment per IPO application regardless of allotment. Subject to Sauda (STS) is a conditional payment that only applies if the seller receives allotment. Kostak includes allotment risk; STS does not.
Where can I check IPO GMP today?
You can check live IPO GMP on our IPO GMP Today tracker. For cross-verification, IPOWatch and InvestorGain are widely followed sources.
Can GMP predict the listing price accurately?
Historically, GMP direction matches listing direction roughly 70 to 75% of the time. The exact magnitude of the listing gain or loss frequently diverges from what GMP implied. Use GMP as one input among several not as a standalone prediction.
Does GMP change every day?
Yes. GMP fluctuates daily based on subscription progress, broader market movements, news about the company, and overall investor sentiment. In highly anticipated IPOs, GMP can change multiple times within a single day.
What does “GMP Seller Only” mean?
This phrase appears on some GMP tracking platforms and means there are sellers in the grey market but no buyers willing to pay the asking price. It is typically interpreted as a negative signal similar to a lower circuit on an exchange indicating weak or deteriorating demand.
Summary: Key Takeaways on IPO GMP
- IPO GMP is the per-share unofficial premium in the grey market before listing
- It is expressed in rupees; the estimated listing price = issue price + GMP
- GMP percentage = (GMP / issue price) × 100
- Kostak is a fixed payment per application regardless of allotment; STS is conditional on allotment
- GMP is unregulated, unverified, and prone to manipulation especially in SME IPOs
- Historical accuracy of GMP direction is roughly 70 to 75%; magnitude accuracy is lower
- Always combine GMP with subscription data, QIB levels, anchor investor quality, and company fundamentals before making a decision
